Critical appraisal of clinical trials in multiple system atrophy: Toward better quality-Reference-Cited by-同舟云学术

Critical appraisal of clinical trials in multiple system atrophy: Toward better quality

Published:2017-08-07 Issue:10 Volume:32 Page:1356-1364
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord.

Author:

Castro Caldas Ana¹²³,Levin Johannes⁴⁵,Djaldetti Ruth⁶,Rascol Olivier⁷,Wenning Gregor⁸,Ferreira Joaquim J.²⁹,

Affiliation:

1. Neurology Service; Department of Neurosciences, Hospital de Santa Maria; Lisbon Portugal

2. Clinical Pharmacology Unit; Instituto de Medicina Molecular; Lisbon Portugal

3. Campus Neurológico Sénior; Torres Vedras Portugal

4. Department of Neurology; Ludwig-Maximilians-Universität München; Munich Germany

5. German Center for Neurodegenerative Diseases; Munich Germany

6. Department of Neurology; Rabin Medical Center; Beilinson Campus, Petach Tikva Israel

7. Department of Neurosciences and Clinical Pharmacology; Reference Center for MSA, Clinical Investigation Center (CIC) 1436, and NeuroToul Center of Excellence in Neurodegeneration (COEN) Center, University of Toulouse, Institut national de la santé et de la recherche médicale (INSERM), University Hospital of Toulouse; Toulouse France

8. Department of Neurology; University Hospital; Innsbruck Austria

9. Laboratory of Clinical Pharmacology and Therapeutics; Faculty of Medicine, University of Lisbon; Lisbon Portugal

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Reference82 articles.

1. Multiple system atrophy-the nature of the beast;Quinn;J Neurol Neurosurg Psychiatry,1989

2. Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study;Schrag;Lancet,1999

3. Prevalence of multiple system atrophy;Tison;Lancet,2000

4. The natural history of multiple system atrophy: a prospective European cohort study;Wenning;Lancet Neurol,2013

5. Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy;Wakabayashi;Neurosci Lett,1998

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Unified Multiple System Atrophy Rating Scale: Status, Critique, and Recommendations;Movement Disorders;2022-09-08

2. Phase I Trial of Intra-arterial Administration of Autologous Bone Marrow-Derived Mesenchymal Stem Cells in Patients with Multiple System Atrophy;Stem Cells International;2021-10-19

3. Current experimental disease-modifying therapeutics for multiple system atrophy;Journal of Neural Transmission;2021-08-16

4. Fluoxetine for the Symptomatic Treatment of Multiple System Atrophy: The MSA‐FLUO Trial;Movement Disorders;2021-04

5. Atypical parkinsonism, parkinsonism-plus syndromes and secondary parkinsonian disorders;Principles and Practice of Movement Disorders;2021